<SEC-DOCUMENT>0001144204-18-038873.txt : 20180718
<SEC-HEADER>0001144204-18-038873.hdr.sgml : 20180718
<ACCEPTANCE-DATETIME>20180718165048
ACCESSION NUMBER:		0001144204-18-038873
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180718
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180718
DATE AS OF CHANGE:		20180718

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		18958828

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		203 787 7888

	MAIL ADDRESS:	
		STREET 1:		4 SCIENCE PARK
		CITY:			NEW HAVEN
		STATE:			CT
		ZIP:			06511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv498815_8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B><BR>
<B>WASHINGTON, D. C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 2in">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B><BR>
<B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B><BR>
<B>SECURITIES EXCHANGE ACT OF 1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event
reported): July 18, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>PRECIPIO,
INC.</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(Exact Name of Registrant as Specified in Its Charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><I>(State of Incorporation)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>001-36439</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><I>(Commission File Number)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1789357</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><I>(I.R.S. Employer Identification No.)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4 Science Park, New Haven, CT 06511</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Address of principal executive offices)
(Zip Code)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(203) 787-7888</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Registrant's telephone number, including
area code)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 2in">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B><BR>
<I>(Former name, former address and former fiscal year, if changed since last report date)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 2in">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Written
                                         communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Soliciting
                                         material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement
                                         communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
                                         </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement
                                         communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
                                         </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Emerging growth company </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 2.02</B></TD><TD STYLE="text-align: justify"><B>Results of Operations and financial Conditions</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On July 18, 2018, the Company issued a
press release announcing its preliminary, unaudited revenue for the second quarter of 2018. A copy of the press release issued
by the Company is furnished as Exhibit 99.1 to this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information in this Current Report
on&nbsp;Form&nbsp;8-K&nbsp;furnished under this Item&nbsp;2.02 including Exhibit 99.1 is furnished and shall not be deemed &ldquo;filed&rdquo;
for any purpose, including for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into
any other filing under the Exchange Act or under the Securities Act, regardless of any general incorporation language in such
filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><FONT STYLE="font-size: 10pt"><B>Item 9.01</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><B>Financial
                                         Statements and Exhibits.</B></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Exhibits.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 1in; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><B>No.</B></FONT></TD>
    <TD STYLE="width: 0.2in; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 1.2in"><A HREF="tv498815_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1</A></TD><TD><A HREF="tv498815_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release dated July 18, 2018&nbsp;</A></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>PRECIPIO, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 44%; border-bottom: black 1pt solid">s/ Ilan Danieli</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>Ilan Danieli</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Executive Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&nbsp;July 18, 2018&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv498815_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Precipio Announces 213% Year-over-Year
Revenue Growth in Preliminary Q2-2018 Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Third consecutive quarter of triple-digit
YoY Quarterly growth</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEW HAVEN, CT, (July 18<SUP>th</SUP>, 2018) &ndash; </B>Specialty
cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO),
today announced preliminary second quarter results representing continued triple digit YoY growth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Quarter over quarter sequential growth was 14% which, at a compounded
run rate of circa 70% annually currently represents early stage growth generated from pathology services. We expect a continuation
of this rate throughout 2018, as the expanding pathology services sales organization ramps, and our ICE COLD PCR liquid biopsy
cancer detection products segment gains commercial traction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On a preliminary basis, revenue for the second quarter is expected
to be $815,000, up from $260,000 in Q2-2017, an increase of 213%. In Q4-2017 and in Q1-2018, YoY revenue growth was 199% and 187%
respectively, showing continued triple-digit YoY growth. Revenue for the first half of 2018 is estimated at $1.5M, a tripling of
revenue from $0.5M in the first half of 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sales of Precipio pathology services were the primary contributor
to the second quarter&rsquo;s revenues, which benefited from integration of the business segment&rsquo;s recently expanded sales
team and increased awareness of the value proposition of academic expertise and cancer pathology specialization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s ICP sales growth plan remains focused on
hospitals, large CRO&rsquo;s, OEM&rsquo;s and national scale labs, with the goal of capturing a substantial share of the multi-billion
dollar liquid biopsy market opportunity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;These results represent further validation of our high
growth strategy to rapidly gain pathology services market share, and commercialize our unique liquid biopsy, mutation detection
products for cancer,&rdquo; commented CEO Ilan Danieli. &ldquo;We are confident with the potential effect on market and enterprise
value resulting from this trend, as we continue to hit revenue and commercialization milestones.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Precipio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Precipio has built a platform designed to eradicate the problem
of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality
diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions
specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard&rsquo;s Dana-Farber
Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information,
please visit <FONT STYLE="color: blue"><U>www.precipiodx.com</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements in this press release constitute &ldquo;forward-looking
statements,&rdquo; within the meaning of federal securities laws, including statements related to ICP technology, including financial
projections related thereto and potential market opportunity, plans and prospects and other statements containing the words &ldquo;anticipate,&rdquo;
&ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. The Company's actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results
or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company&rsquo;s
definitive proxy statement filed on May 29, 2018, the Company&rsquo;s Quarterly Report on Form 10-Q for the quarter ended March
31, 2018 and on the Annual Report on Form 10-K for the year ended December 31, 2017 as well as the Company&rsquo;s prior filings
and from time to time in the Company&rsquo;s subsequent filings with the Securities and Exchange Commission. Any change in such
factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred
to in such statements. All information in this press release is as of the date of the release and the Company does not undertake
any duty to update this information, including any forward-looking statements, unless required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inquiries:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC"><B><U>investors@precipiodx.com</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>+1-203-787-7888</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !! 4T# 2(  A$! Q$!_\0
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M,N(]Z[>XQZUR_P#97Q+_ .ABT?\ \!3_ /$UWM%4I6%8X+^ROB7_ -#%H_\
MX"G_ .)JO=7WQ$\-QF]OHM/UNRC&Z9;93'(J]R.!_(UZ+24^?ND%C.T+7++Q
M%I$&I6#[H91T/5&'53[BL?7K'QI<:HTFAZQIUK8[ !'/ 6<-W.<&LGX>(EMX
MB\86=K@6,.H Q*OW58@[@/R%>@4-<LM 6J."_LKXE_\ 0Q:/_P" I_\ B:#I
M?Q,[>(='/_;J?_B:[VBCG\E]P6//K/QCKF@:O;Z9XSLH(X[EMD&HVQ_=,WHP
M[?I].]=MJ4SVVEW=Q'@210NZY&1D*2*YWXE6]M<> -6^TXQ'$)(R?X7!&TCW
M[?C5NTEFG^'<4MQGSGTL,^>I/E4-)I2#R.1\.GXA>(]!M=6@\26$4=PI(1[-
M21@D=A[5I_V+\1_^AITW_P  Q_A5[X7_ /).='_W'_\ 0VKKZ<I-2:LON$EH
M<%_8OQ'_ .AITW_P#'^%+_8OQ'R/^*JTW_P#'^%=Y12YWY?<.PV,,$ <Y; R
M0,9-9^MZ[IWA[3GOM2N%AA7@=V<^BCN:T'8(A9B H&23V%>;^';/_A/O$EQX
MGU-/,TNTE,.F6S_<.T\R$=_\?I2BD]7L#)XO$7C?Q,/-T'1K?3+!ON7.HDEW
M'J%'^!^M3?V3\2_^ADTC_P !?_L:[T#%%/G[)!8X$Z3\3,<>)-(_\!?_ +&N
MIU>YNM/\*WEUYB&\M[-WWA?E,@0G('IGM6K61XJ_Y%'6/^O*7_T TKW:"Q#X
M/U"ZU;P=IE_=R![J>W#.^W +>N!6 =*^)6XX\0Z.!GC_ $4]/^^:UOAY_P D
M^T3_ *]E_F:Z:FWRR=@Z'!?V5\2_^ABT?_P%/_Q--DL?B=;H98]7T:[9>?),
M!7=[9P*[^BCG\E]P6.3\)^,6UNZN-)U2R.G:W:C,ULQR'7^\A[CI^8ZT?$/6
MK[0?#27FG2K%.;J*,L5#?*6Y&#65XM1+?XE>#[JVXNYGEAEQU:+'?V&34OQ;
M_P"1-C_Z_H/_ $*J45S)]Q7T.['05B^)/%.E^%[(7&H2G>YQ#!&-TDI]%']:
MT;V]AT[39KVX;;#!$9'/L!DUPW@?29/$-X_C;6D\RZN6/V"%^5MX0< @>I]?
MQ[U$4K7>PQT>I?$/Q !-8:?8Z):-RAO<O*1ZD=ORI[6OQ-L1YJ:AHVI =86B
M,9/T( _G7?=**?/Y(+'&Z#X\CO-2&C:Y8R:/J_189C\DO^XW?Z?SKLLUA>*O
M"]EXITE[2X4).OS6]P/O0OV(/IZBLWP#KUUJFE7%AJIQJNERFVN2?X\?=;\0
M#^5#2:N@.LDBCFC,<J*Z'@JPR#7+:I\/](OMSVP:RE/>+E?^^3_3%=93!+&>
MDB'_ ($*RE",E:2)G3A-6DKGD.J>!]9TXLT<0NX1_'!R<>Z]?YU2T+7[SP[?
M%XPQC)Q-;MQN_P #[U[:,'H16=J6@Z9JZXO;2.1L<.!AA^(YKEEA;/FINS.&
M6!Y7S4G9DFE:K::Q8I=VDF]&Z@]5/H1V-7JXN'PC?:!??;-!O=Z'_66MSP''
MIN'?T.*ZZVF::!7>%X7(^:-^JG\.#]:Z(2DU:2U.VE*;5IJS)L9KR?Q_X932
M[E=3LDV6T[XD1>!')UR/0'^=>L5Y1\5+N_AU.UMENY1930[_ "0<+N!Y)]>U
M=6'3=1)$UX*4-3IO"GC*SOK*RL;ZY U1R8MA!R^!D,?3(_6NQS7S?I-PUGK-
MC<H<-%<(W_CPKZ0JL125.2MU'2DVK,Q/%/B6W\*Z4M_<P33J\JPK'"!N+'..
MOTKG/^%F2?\ 0HZ__P" U+\6Q_Q2]B?34H/ZUWM9>ZHIM&AP/_"S)/\ H4=?
M_P# >H+GQEXFUR(V?A[PQ?6DTGRF[OUV)$/7'<_YP:]%HHYH]@LS \(^&HO"
MVB+9B4SW,CF6YG/620]3].PK-USX@P:/K\NCQZ/J-_<Q1K(_V6,-@-TXZUV-
M<%IO_);-:_[!D7\UHCJVY Q/^%F2?]"CK_\ X#4?\+,D/3PCK_\ X#5WU8OB
MNUU.\\-WD6CW4EMJ 3?"Z=25.=OXXQ^-"<6]OQ#4XZ>S\1?$2[@AU+3I-&\.
MQ2"22&5OWUR1T!'8?YYKN]618_#]\B*%5;60 #H!L-9_@WQ$GB;PY;WQ 6X'
M[JYCZ%)5^\,?K^-:6L_\@/4/^O:3_P!!-$F[V[ </X0UJ30OA1HMU'IEYJ!.
MY/*M$W,,NW)]O\:L?\+(N_\ H3-?_P"_%7_A?_R3G1_]Q_\ T-JZ^G)KF=T"
MV.%@^(MU-<11'P=KR;W"[C!P,G&:[JBBH;3V0&'XRN)+7P9K,T1(=;.3!';Y
M2*@\!6T=KX$T6.,#!M5<^Y;D_J:U]5L5U/2;RP?A;B%XB3VW C-<I\,-3:;P
MT=&N1LU#2)&M9XSU !.T_3''X52^!AU.WHHHJ!A61XJ_Y%'6/^O*7_T UKUD
M>*O^11UC_KRE_P#0#36Z SO #B/X=Z,[=%M 3^M8EO\ %:*\B\VT\,ZW<0Y(
M$D4(93CW!K8\"_\ )-=)_P"O/_&J'PC_ .1!@_Z^)O\ T*M&EJVNI)'_ ,+,
MD_Z%'7__  &I&^)%Y*-EIX-UV2<_=5X=JD^Y[5W]%3S1_E_$>IP_ACP]J]UK
M\GBKQ-Y:7YC\JULXSE;9#U_'_$_A'\6_^1-B_P"OZ#_T*N[Q7"?%O_D38O\
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MJ'W((%9FE"XN+:!X=4!CC 5X?LZJ4QU0^A'2FEU TXKQ9;DV[(T<PB64JV.
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#3__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
